GUSS BENGT has a total of 21 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ANTISOMA LTD, UNITED NEUROSCIENCE and IN3BIO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Canada | 2 | |
#5 | Sweden | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Guss Bengt | 21 |
#2 | Frykberg Lars | 16 |
#3 | Flock Jan-Ingmar | 12 |
#4 | Flock Margareta | 11 |
#5 | Jacobsson Karin | 9 |
#6 | Bergman Rune | 5 |
#7 | Janzon Kenneth | 5 |
#8 | Lindberg Martin | 4 |
#9 | Jonsson Hans | 4 |
#10 | Rantamaeki Liisa K | 3 |
Publication | Filing date | Title |
---|---|---|
US2013236469A1 | Vaccine against streptococcal infections based on recombinant proteins | |
EP2498812A1 | Immunizing composition for reducing streptococcal infections | |
CA2501621A1 | Immunization of non-human mammals against streptococcus equi | |
WO0037496A1 | Novel fibronectin-binding protein | |
WO9507296A1 | Method and means for producing plasmaproteinase inhibitor-binding proteins | |
WO9507300A1 | Methods and means for producing a plasmaprotein-binding protein |